CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
The clinical outcomes of second-line chemotherapy in patients with advanced pancreatic cancer: a retrospective analysis
Hyun yeb Jung, Eun Mi Lee

DOI: https://doi.org/10.12701/yujm.2021.01347

Excel Download

Clinical outcomes of conversion surgery after neoadjuvant chemotherapy in patients with borderline resectable and locally advanced unresectable pancreatic cancer: A single-center, retrospective analysis
Pancreatology. 2019;19:S110   Crossref logo
Link1 Link2

1166 PUBLICATION Effect of second-line chemotherapy on survival of patients with advanced non-small cell lung cancer pre-treated with docetaxel-based front-line chemotherapy: a retrospective survival analysis
European Journal of Cancer Supplements. 2005;3(2):337   Crossref logo
Link1 Link2

A Retrospective Analysis of Second-Line Chemotherapy or Best Supportive Care in Patients with Advanced-Stage Non–Small-Cell Lung Cancer
Clinical Lung Cancer. 2006;8(1):49-55   Crossref logo
Link1 Link2

Second line chemotherapy for advanced pancreatic cancer patients in Japan
Annals of Oncology. 2019;30:vi30   Crossref logo
Link1 Link2 Link3 Link4

Second-line chemotherapy in advanced pancreatic cancer patients before nab-paclitaxel introduction. Retrospective study in Reggio Emilia Clinical Cancer Centre
Annals of Oncology. 2016;27:iv23   Crossref logo
Link1 Link2 Link3

Gemcitabine Plus Nab-Paclitaxel as Second-Line Chemotherapy following FOLFIRINOX in Patients with Unresectable Pancreatic Cancer: A Single-Institution, Retrospective Analysis
Chemotherapy. 2021;66(3):58-64   Crossref logo
Link1 Link2

Retrospective analysis of second-line chemotherapy outcomes with paclitaxel or docetaxel in correlation with STMN1 polymorphism in advanced non-small cell lung cancer patients
Clinical and Translational Oncology. 2015;18(1):33-39   Crossref logo
Link1 Link2 Link3

148PD OUTCOMES OF SMALL CELL LUNG CANCER (SCLC) PATIENTS TREATED WITH SECOND-LINE CHEMOTHERAPY (SL): A RETROSPECTIVE ANALYSIS OF 166 PATIENTS
Lung Cancer. 2009;64:S62   Crossref logo
Link1 Link2

P-180 Second-line treatment after disease progression following first-line chemotherapy with modified FOLFIRINOX in advanced pancreatic cancer patients: a single institution retrospective cohort study
Annals of Oncology. 2015;26:iv52   Crossref logo
Link1 Link2 Link3

Retrospective Analysis of Third-Line and Fourth-Line Chemotherapy for Advanced Non–Small-Cell Lung Cancer
Clinical Lung Cancer. 2012;13(1):39-43   Crossref logo
Link1 Link2